Glass Lewis Backs Radoff-JEC Group's Board Challenge at Seer
Event summary
- Radoff-JEC Group, owning 7.7% of Seer's stock, secures Glass Lewis' support for its board challenge.
- Glass Lewis recommends voting for Radoff-JEC nominees Howard H. Berman and Luis E. Rinaldini.
- Proxy advisor cites Seer’s operating losses and share price underperformance as reasons for board change.
- Glass Lewis also advises against ratification of Seer's NOL pill, adopted post-dissident disclosure.
The big picture
Seer's prolonged underperformance and governance concerns have escalated into a full-blown proxy fight, with two major proxy advisors siding against incumbent directors. This challenge reflects broader trends in biotech where activist investors push for board refreshment to unlock value amid commercialization struggles. The outcome will test whether targeted board changes can realign executive incentives with shareholder interests.
What we're watching
- Board Composition Shift
- Whether the election of Radoff-JEC nominees will lead to a credible strategic review process at Seer.
- Strategic Alternatives
- How the board will evaluate standalone strategy versus partnerships or asset transactions under new leadership.
- Shareholder Sentiment
- The pace at which institutional investors align with proxy advisors' recommendations ahead of the July 28th annual meeting.
Related topics